Additionally, the levels of AKT and PI3K phosphorylation are increased in pancreatic cancer cells that overexpress CCNI2, and treating these cells with a PI3K inhibitor can partially reverse this effect (Figure 5D). This evidence concerns the gene CCNI2 and familial pancreatic carcinoma.